Websites, domains, hosts that links to actelion.us
Our database shows, that the website actelion.us is linked by a total of 7 websites.
Number of websites/domains displayed: 7
Results found: 7
Websites discovered:
PAH Treatment OPSUMIT® (macitentan)http://pageoverview.com/website-report/opsumit.com
Learn about pulmonary arterial hypertension treatment with OPSUMIT® (PAH, WHO Group 1).
- Expected expiration: January 7th in 2018
- Creation date: January 7th in 2011
- Renew date: January 3rd in 2017
- Google Analytics: 50780211-1
Official PAH* and VENTAVIS Informationhttp://pageoverview.com/website-report/4ventavis.com
Learn more about PAH and VENTAVIS at 4ventavis.com.
- Expected expiration: January 31st in 2019
- Creation date: January 31st in 2005
- Renew date: January 27th in 2018
- Google Analytics: 50601306-1
Actelion Pharmaceuticals US, Inchttp://pageoverview.com/website-report/actelion.us
Actelion Pharmaceuticals Ltd is a biopharmaceutical company, that focuses on the discovery, development and commercialization of innovative treatments to serve high unmet medical needs.
- Expected expiration: May 6th in 2017
- Creation date: May 6th in 2002
- Renew date: March 2nd in 2012
Actelion Pharmaceuticals Ltd - Shaping our Futurehttp://pageoverview.com/website-report/actelion.com
Actelion Pharmaceuticals Ltd is a biopharmaceutical company, that focuses on the discovery, development and commercialization of innovative treatments to serve high unmet medical needs.
- Expected expiration: January 14th in 2018
- Creation date: January 15th in 1998
- Renew date: January 10th in 2017
UPTRAVI® (selexipag) PAH Treatmenthttp://pageoverview.com/website-report/uptravi.com
Learn about UPTRAVI, a pulmonary arterial hypertension (PAH, WHO Group 1) treatment.
- Expected expiration: January 4th in 2019
- Creation date: January 4th in 2011
- Renew date: December 31st in 2017
Stage IA & IB mycosis fungoides–type cutaneous t-cell lymphoma | VALCHLOR (mechlorethamine)http://pageoverview.com/website-report/valchlor.com
Information for patients about an FDA-approved topical prescription medicine for Stage IA & IB mycosis fungoides–type cutaneous t-cell lymphoma. Find important safety information medication guide and prescribing information.
- Expected expiration: October 25th in 2017
- Creation date: October 25th in 2011
- Renew date: October 21st in 2016
- Google Analytics: 55588032-1